John Hale, PhD

Company: BLIS Technologies
Job title: Chief Technology Officer
Seminars:
Micrococcus luteus BLIS Q24™ – Development of a Novel Skin Probiotic Strain & Formulation 3:35 pm
Characterising a new probiotic strain for skin health applications Formulating BLIS Q24™ into an appropriate topical delivery system The emerging evidence base supporting BLIS Q24™Read more
day: Day One